Ocean Biomedical, Inc. (OCEA) stock
OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)
Close on Oct 19, 2026Market cap $45.51KP/E –Yield –
Ocean Biomedical EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Ocean Biomedical's EPS for the twelve months ending Mar 31, 2025 was -$0.91. For fiscal 2024 it was -$0.34.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | -$0.34 | – |
| FY2023 | Dec 31, 2023 | -$4.35 | – |
| FY2022 | Dec 31, 2022 | -$0.74 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | -$0.09 | -118.8% |
| Q4 FY2024 | Dec 31, 2024 | -$0.06 | – |
| Q3 FY2024 | Sep 30, 2024 | -$0.13 | – |
| Q2 FY2024 | Jun 30, 2024 | -$0.63 | – |
| Q1 FY2024 | Mar 31, 2024 | $0.48 | – |
| Q4 FY2023 | Dec 31, 2023 | -$0.62 | – |
| Q3 FY2023 | Sep 30, 2023 | -$0.53 | – |
| Q2 FY2023 | Jun 30, 2023 | -$0.43 | – |
| Q1 FY2023 | Mar 31, 2023 | -$2.90 | – |
| Q4 FY2022 | Dec 31, 2022 | -$0.04 | – |
| Q3 FY2022 | Sep 30, 2022 | -$0.16 | – |
| Q2 FY2022 | Jun 30, 2022 | -$0.31 | – |
| Q1 FY2022 | Mar 31, 2022 | -$0.23 | – |
| Q3 FY2021 | Sep 30, 2021 | -$0.02 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?